UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000052756
Receipt number R000060195
Scientific Title Acceptability Study of Electric Taste Devices
Date of disclosure of the study information 2024/03/31
Last modified on 2023/11/10 13:45:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Acceptability Study of Electric Taste Devices

Acronym

Acceptability Study of Electric Taste Devices

Scientific Title

Acceptability Study of Electric Taste Devices

Scientific Title:Acronym

Acceptability Study of Electric Taste Devices

Region

Japan


Condition

Condition

No

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigating the effects of applying weak transdermal electrical stimulation to saline water and food.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Taste intensity, Palatability

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Intervention period of one day. Under the condition of administering weak transcutaneous electrical stimulation, NaCl aqueous solution and food are consumed. Verify how the presence or absence of electrical stimulation changes the taste and preference of the NaCl aqueous solution and food.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Persons who are 20 years of age or older at the time of obtaining consent
(2) Japanese nationals
(3) Persons who understand the research and give written consent.

Key exclusion criteria

1. have lacerations or other injuries in the oral cavity
2. has a pacemaker, artificial heart lung, or other medical electrical device implanted in your body
3. have any kind of heart disease
4. have any kind of brain disease
5. have a malignant tumor
6. have a cold or other health problems
7. sweating profusely during exercise, etc.
8. having any disease of the tongue or oral cavity
9. has pain caused by electrical stimulation due to cavity filling, dental implant, or orthodontic treatment
10. having seizures due to epilepsy of any degree
11. pregnant or possibly pregnant
12. has a piercing in any part of the face (ear, nose, lip, tongue, etc.) (metal fittings that can be removed immediately may participate if they can be removed at the time of the study)

Target sample size

77


Research contact person

Name of lead principal investigator

1st name Nobuhisa
Middle name
Last name Shimba

Organization

Ajinomoto Co., Inc.

Division name

R&B Planning Department

Zip code

104-8315

Address

1-15-1 Kyobashi, Chuo-ku, Tokyo

TEL

03-5250-8111

Email

nobuhisa.shimba.q7s@asv.ajinomoto.com


Public contact

Name of contact person

1st name Ryo
Middle name
Last name Matsumoto

Organization

Ajinomoto Co., Inc.

Division name

R&B Planning Department

Zip code

104-8315

Address

1-15-1 Kyobashi, Chuo-ku, Tokyo

TEL

070-4017-7889

Homepage URL


Email

ryo.matsumoto.zp9@asv.ajinomoto.com


Sponsor or person

Institute

Ajinomoto Co., Inc.

Institute

Department

Personal name



Funding Source

Organization

Ajinomoto Co., Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

University of Tokyo

Name of secondary funder(s)



IRB Contact (For public release)

Organization

AJINOMOTO INSTITUTIONAL REVIEW BOARD

Address

1-15-1 Kyobashi, Chuo-ku, Tokyo

Tel

03-5250-8111

Email

ajinomoto_irb@asv.ajinomoto.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2023 Year 10 Month 05 Day

Date of IRB

2023 Year 10 Month 05 Day

Anticipated trial start date

2023 Year 11 Month 20 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2024 Year 02 Month 29 Day


Other

Other related information



Management information

Registered date

2023 Year 11 Month 10 Day

Last modified on

2023 Year 11 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060195


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name